Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation.
COVID-19
Long-COVID syndrome
OCT–angiography
chronic fatigue syndrome
functionally GPCR autoantibodies
glaucoma
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
29 Jun 2022
29 Jun 2022
Historique:
received:
28
05
2022
revised:
23
06
2022
accepted:
24
06
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
14
7
2022
Statut:
epublish
Résumé
Long COVID (LC) describes the clinical phenotype of symptoms after infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Diagnostic and therapeutic options are limited, as the pathomechanism of LC is elusive. As the number of acute SARS-CoV-2 infections was and is large, LC will be a challenge for the healthcare system. Previous studies revealed an impaired blood flow, the formation of microclots, and autoimmune mechanisms as potential factors in this complex interplay. Since functionally active autoantibodies against G-protein-coupled receptors (GPCR-AAbs) were observed in patients after SARS-CoV-2 infection, this study aimed to correlate the appearance of GPCR-AAbs with capillary microcirculation. The seropositivity of GPCR-AAbs was measured by an established cardiomyocyte bioassay in 42 patients with LC and 6 controls. Retinal microcirculation was measured by OCT-angiography and quantified as macula and peripapillary vessel density (VD) by the Erlangen-Angio Tool. A statistical analysis yielded impaired VD in patients with LC compared to the controls, which was accentuated in female persons. A significant decrease in macula and peripapillary VD for AAbs targeting adrenergic β2-receptor, MAS-receptor angiotensin-II-type-1 receptor, and adrenergic α1-receptor were observed. The present study might suggest that a seropositivity of GPCR-AAbs can be linked to an impaired retinal capillary microcirculation, potentially mirroring the systemic microcirculation with consecutive clinical symptoms.
Identifiants
pubmed: 35806214
pii: ijms23137209
doi: 10.3390/ijms23137209
pmc: PMC9266742
pii:
doi:
Substances chimiques
Adrenergic Agents
0
Autoantibodies
0
Receptors, G-Protein-Coupled
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Federal Ministry of Education and Research
ID : 01EP2108A
Références
J Transl Autoimmun. 2021;4:100100
pubmed: 33880442
J Biomed Opt. 2007 Jan-Feb;12(1):014024
pubmed: 17343499
Biomed Biochim Acta. 1987;46(8-9):S634-9
pubmed: 2449194
EClinicalMedicine. 2021 Aug;38:101019
pubmed: 34308300
Clin Exp Immunol. 1988 Dec;74(3):349-54
pubmed: 2853016
J Mol Cell Cardiol. 2009 Jan;46(1):15-24
pubmed: 18848837
Vasa. 2014 Sep;43(5):347-52
pubmed: 25147011
Biomedicines. 2021 Aug 04;9(8):
pubmed: 34440161
Circ Res. 2013 Apr 12;112(8):1104-11
pubmed: 23446738
J Thromb Haemost. 2021 Oct;19(10):2546-2553
pubmed: 34375505
J Biol Chem. 2006 May 12;281(19):13275-13284
pubmed: 16513650
Klin Monbl Augenheilkd. 2021 Dec;238(12):1294-1298
pubmed: 34879428
PLoS One. 2020 Nov 9;15(11):e0240784
pubmed: 33166287
Cell. 2001 Sep 7;106(5):619-32
pubmed: 11551509
Neurosci Lett. 2021 Apr 1;749:135724
pubmed: 33600909
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
J Pharm Pharm Sci. 2021;24:84-93
pubmed: 33626315
Cardiovasc Diabetol. 2021 Aug 23;20(1):172
pubmed: 34425843
J Clin Apher. 2016 Aug;31(4):368-74
pubmed: 26011726
Methods Mol Biol. 2019;1955:247-261
pubmed: 30868533
Medicine (Baltimore). 2016 Oct;95(41):e4907
pubmed: 27741104
Nat Med. 2021 Sep;27(9):1607-1613
pubmed: 34163090
Acta Paediatr. 2021 Mar;110(3):914-921
pubmed: 33205450
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
J Ocul Pharmacol Ther. 2009 Feb;25(1):23-8
pubmed: 19232015
Herz. 2000 May;25(3):261-6
pubmed: 10904849
Hypertens Res. 2002 Jul;25(4):641-6
pubmed: 12358154
Autoimmun Rev. 2021 Apr;20(4):102792
pubmed: 33610751
Appl Sci (Basel). 2017 Jul;7(7):
pubmed: 30009045
J Biol Chem. 2011 Dec 30;286(52):44739-49
pubmed: 22069323
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Transplantation. 2012 Jul 15;94(1):8-13
pubmed: 22691955
PLoS One. 2018 Mar 14;13(3):e0192778
pubmed: 29538413
Front Immunol. 2018 Feb 12;9:145
pubmed: 29483909
Acta Diabetol. 2019 Jun;56(6):659-665
pubmed: 30770998
J Clin Med. 2020 Jul 30;9(8):
pubmed: 32751659
BMJ Open. 2021 Mar 30;11(3):e048391
pubmed: 33785495
Int J Mol Med. 2003 Aug;12(2):225-30
pubmed: 12851722
Eur J Pharmacol. 2003 Apr 11;466(1-2):1-6
pubmed: 12679135
Circ Res. 2011 Oct 14;109(9):986-92
pubmed: 21868696
Blood Press Suppl. 1996;3:31-6
pubmed: 8973766
J Transl Autoimmun. 2021 Aug 14;4:100112
pubmed: 34471867
Semin Immunopathol. 2014 May;36(3):351-63
pubmed: 24777744
Cell Mol Immunol. 2007 Apr;4(2):127-33
pubmed: 17484807
Immunity. 2019 May 21;50(5):1163-1171.e5
pubmed: 31027996
Can J Ophthalmol. 2021 Feb;56(1):24-30
pubmed: 33249111
Br J Pharmacol. 2013 Jun;169(3):477-92
pubmed: 23488800
Circulation. 2007 Jul 24;116(4):399-410
pubmed: 17620508
Can J Physiol Pharmacol. 2003 Feb;81(2):79-83
pubmed: 12710518
J Biol Chem. 2003 Nov 7;278(45):44400-4
pubmed: 12915402
J Am Heart Assoc. 2019 Sep 17;8(18):e013602
pubmed: 31495251
J Exp Med. 1995 Jul 1;182(1):59-65
pubmed: 7790824
Cell Death Differ. 2021 Nov;28(11):3125-3139
pubmed: 34031543
Microb Pathog. 2021 Apr;153:104799
pubmed: 33609650
medRxiv. 2021 Feb 28;:
pubmed: 33655272
Inflamm Res. 2015 Apr;64(3-4):253-60
pubmed: 25721616
Int J Infect Dis. 2020 Nov;100:327-332
pubmed: 32920235
Heliyon. 2017 Jul 31;3(7):e00362
pubmed: 28795160
J Am Heart Assoc. 2020 Aug 4;9(15):e015989
pubmed: 32750291
Case Rep Oncol. 2013 Jan;6(1):104-8
pubmed: 23569443
Front Med (Lausanne). 2021 Jul 09;8:676554
pubmed: 34307408
Infect Dis Poverty. 2020 Apr 28;9(1):45
pubmed: 32345362
EBioMedicine. 2020 Aug;58:102925
pubmed: 32745993
Ophthalmologica. 2020;243(1):75-84
pubmed: 31509842
Adv Exp Med Biol. 2012;749:187-99
pubmed: 22695846
Front Med (Lausanne). 2021 Nov 18;8:754667
pubmed: 34869451
Brain Behav Immun. 2016 Feb;52:32-39
pubmed: 26399744
Phys Rev Lett. 2004 Jul 9;93(2):028102
pubmed: 15323954
Life Sci. 1999;64(6-7):465-9
pubmed: 10069511
Eur J Intern Med. 2020 Jun;76:14-20
pubmed: 32336612
Eur Heart J. 1991 Aug;12 Suppl D:178-81
pubmed: 1717272
Am J Med. 2021 Dec;134(12):1451-1456
pubmed: 34390682